The Stanley Laboratory works at the intersection of three areas:

Radiogenetics and Magnetogenetics
We are pioneering the use of radio waves and magnetic fields to stimulate individual cells and neurons - a technique that, like optogenetics, has broad research and therapeutic applications but which is non-invasive.

Nanobioengineering
We are developing the use of nanoparticles in bioengineered murine models for preclinical applications using ferritin and other naturally occurring nanoparticles.

Neuroendocrinology of diabetes
We are advancing the understanding of the interaction between central and peripheral systems in, and beyond, appetite control to find new approaches to Diabetes prevention and treatment.

We are fortunate to work in close collaboration with colleagues across Mount Sinai and in partnerships with Professor Jeffrey Friedman, Rockefeller University, and Professor Jonathan Dordick, Rensselaer Polytechnic Institute.  Currently, our work is funded by The National Institutes of Health and American Diabetes Association.